MIT Professor Darrell Irvine describes a novel vaccine adjuvant: a nanoparticle that can help stimulate the immune system to generate a stronger response to a vaccine. An HIV vaccine with this adjuvant will be tested in clinical trials.
Expert discusses making HIV vaccines more powerful medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
MIT Koch Institute researchers develop a cancer treatment combining immune checkpoint blockade therapy with STING. The resulting vaccine eliminates most tumors and prevents recurrence in mice, with minimal side effects.